Research graph
References from Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase – Design, synthesis and biological evaluation. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/j.neuron.2004.09.010
10.1016/j.neuron.2004.09.010 · External reference
10.1016/s1474-4422(03)00502-7
10.1016/s1474-4422(03)00502-7 · External reference
10.1097/01.jnen.0000228136.58062.bf
10.1097/01.jnen.0000228136.58062.bf · External reference
10.1016/s0140-6736(20)32205-4
10.1016/s0140-6736(20)32205-4 · External reference
Selective loss of central cholinergic neurons in Alzheimer's disease
10.1016/s0140-6736(76)91936-x · 1976 · External reference
Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia
10.1136/bmj.2.6150.1457 · 1978 · External reference
Cortical neuropathological and neurochemical substrates of alzheimer's and parkinson's diseases
1987 · External reference
Acetylcholinesterase: a multifaceted target for structure-based drug design of anticholinesterase agents for the treatment of Alzheimer's disease
10.1385/jmn:20:3:369 · 2003 · External reference
10.1016/s0969-2126(99)80040-9
10.1016/s0969-2126(99)80040-9 · External reference
Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy
10.1111/jphp.12919 · 2018 · External reference
Functionaliseddihydroazo pyrimidine derivatives from Morita–Baylis–Hillman acetates: synthesis and studies against acetylcholinesterase as its inhibitors
10.1039/c6ra12507g · 2016 · External reference
Donepezil hydrochloride: a treatment drug for Alzheimer's disease
10.1002/1528-0691(2001)1:1<63::aid-tcr9>3.0.co;2-j · 2001 · External reference
Galantamine hydrobromide: an agent for Alzheimer's disease
10.1093/ajhp/60.5.446 · 2003 · External reference
Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease
10.1592/phco.20.1.1.34664 · 2000 · External reference
10.1016/s0014-2999(01)01030-5
10.1016/s0014-2999(01)01030-5 · External reference
Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type
10.1016/s0165-0173(00)00051-5 · 2001 · External reference
10.1146/annurev.pathmechdis.2.010506.092044
10.1146/annurev.pathmechdis.2.010506.092044 · External reference
10.1002/neu.480230915
10.1002/neu.480230915 · External reference
10.1016/j.neuron.2006.03.026
10.1016/j.neuron.2006.03.026 · External reference
10.3233/jad-160763
10.3233/jad-160763 · External reference
The role of NMDA receptors in Alzheimer’s disease
10.3389/fnins.2019.00043 · 2019 · External reference
N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease
10.2174/156720512801322564 · 2012 · External reference
10.1073/pnas.0511065103
10.1073/pnas.0511065103 · External reference
Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1–40)
10.1016/s0006-8993(02)03731-9 · 2002 · External reference
Abeta induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss
10.1073/pnas.1306832110 · 2013 · External reference
10.1111/j.1527-3458.2003.tb00254.x
10.1111/j.1527-3458.2003.tb00254.x · External reference
Memantine: the value of combined therapy
10.33588/rn.5202.2010602 · 2011 · External reference
10.1155/2013/925702
10.1155/2013/925702 · External reference
Memantine, donepezil, or combination therapy—What is the best therapy for Alzheimer’s disease? A network meta-analysis
2020 · External reference
10.3390/ijms21093272
10.3390/ijms21093272 · External reference
A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer’s disease
10.2147/dddt.s86463 · 2016 · External reference
Cumulative, additive benefits of memantine-donepezil combination over component monotherapies in moderate to severe Alzheimer’s dementia: a pooled area under the curve analysis
2015 · External reference
10.1371/journal.pone.0034047
10.1371/journal.pone.0034047 · External reference
10.1523/jneurosci.5828-11.2012
10.1523/jneurosci.5828-11.2012 · External reference
Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase
10.1016/s0022-3565(24)39312-7 · 2000 · External reference
10.1016/j.cell.2009.12.055
10.1016/j.cell.2009.12.055 · External reference
Traumatic brain injury: can the consequences be stopped?
10.1503/cmaj.080282 · 2008 · External reference
10.3171/2014.9.focus14485
10.3171/2014.9.focus14485 · External reference
Hadzimichalis N (2013) NMDA receptor activity in neuropsychiatric disorders
2013 · External reference
10.1038/tp.2017.162
10.1038/tp.2017.162 · External reference
10.1016/j.nurt.2009.07.008
10.1016/j.nurt.2009.07.008 · External reference
The therapeutic potential of tacrine
10.1007/978-3-7091-7508-8_29 · 1998 · External reference
Safety of tacrine: clinical trials, treatment IND, and postmarketing experience
10.1097/00002093-199806000-00007 · 1998 · External reference
Tetrahydroaminoacridine block of N-methyl-D-aspartate-activated cation channels in cultured hippocampal neurons
10.1016/s0026-895x(25)11064-x · 1991 · External reference
Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. Steps toward novel drugs for treating Alzheimer's disease
10.1074/jbc.271.39.23646 · 1996 · External reference
10.1021/jm049112h
10.1021/jm049112h · External reference
Synthesis and biological evaluation of NO-donor-tacrine hybrids as hepatoprotective anti-Alzheimer drug candidates
10.1021/jm701491k · 2008 · External reference
Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties
10.1002/cmdc.200800414 · 2009 · External reference
Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties
10.1021/jm100329q · 2010 · External reference
10.1021/jm201460y
10.1021/jm201460y · External reference
Cystamine-tacrine dimer: a new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment
10.1016/j.neuropharm.2011.10.007 · 2012 · External reference
Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease
10.1016/j.ejmech.2014.01.020 · 2014 · External reference
Tacrine-trolox hybrids: a novel class of centrally active, nonhepatotoxic multi-target-directed ligands exerting anticholinesterase and antioxidant activities with low in vivo toxicity
10.1021/acs.jmedchem.5b01325 · 2015 · External reference
10.1016/j.ejmech.2016.03.077
10.1016/j.ejmech.2016.03.077 · External reference
Novel tacrine derivatives exhibiting improved acetylcholinesterase inhibition: Design, synthesis and biological evaluation
10.1016/j.ejmech.2017.08.013 · 2017 · External reference
10.1021/acs.jmedchem.9b00017
10.1021/acs.jmedchem.9b00017 · External reference
Multi-target-directed ligands and other therapeutic strategies in the search of a real solution for Alzheimer's disease
10.2174/1570159x113116660047 · 2014 · External reference
Multi-target-directed ligands in Alzheimer's disease treatment
10.2174/092986711797535245 · 2011 · External reference
Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease
10.2174/0929867321666141106122628 · 2015 · External reference
Low-dose ladostigil for mild cognitive impairment: a phase 2 placebo-controlled clinical trial
10.1212/wnl.0000000000008239 · 2019 · External reference
From bitopic inhibitors to multitarget drugs for the future treatment of Alzheimer’s disease
10.2174/0929867322666150812145825 · 2015 · External reference
10.1016/j.tips.2020.04.008
10.1016/j.tips.2020.04.008 · External reference
Structure-activity relationships of dually-acting acetylcholinesterase inhibitors derived from tacrine on N-methyl-d-Aspartate receptors
10.1016/j.ejmech.2021.113434 · 2021 · External reference
Pursuing the complexity of Alzheimer’s disease: discovery of fluoren-9-amines as selective butyrylcholinesterase inhibitors and n-methyl-d-aspartate receptor antagonists
10.3390/biom11010003 · 2021 · External reference
7-Methoxyderivative of tacrine is a ‘foot-in-the-door’open-channel blocker of GluN1/GluN2 and GluN1/GluN3 NMDA receptors with neuroprotective activity in vivo
10.1016/j.neuropharm.2018.08.010 · 2018 · External reference
7-phenoxytacrine is a dually acting drug with neuroprotective efficacy in vivo
10.1016/j.bcp.2021.114460 · 2021 · External reference
10.1038/nature10180
10.1038/nature10180 · External reference
Structural elements of a pH-sensitive inhibitor binding site in NMDA receptors
10.1038/s41467-019-08291-1 · 2019 · External reference
10.1016/j.cell.2016.03.028
10.1016/j.cell.2016.03.028 · External reference
10.1038/nature13548
10.1038/nature13548 · External reference
10.1016/0304-3940(88)90228-5
10.1016/0304-3940(88)90228-5 · External reference
10.1016/j.neuron.2005.01.031
10.1016/j.neuron.2005.01.031 · External reference
10.1038/307462a0
10.1038/307462a0 · External reference
10.1016/0304-3940(85)90414-8
10.1016/0304-3940(85)90414-8 · External reference
Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels
10.1073/pnas.85.4.1307 · 1988 · External reference
10.1113/jphysiol.1991.sp018396
10.1113/jphysiol.1991.sp018396 · External reference
10.1016/j.bpj.2017.04.043
10.1016/j.bpj.2017.04.043 · External reference
10.1021/jm300871x
10.1021/jm300871x · External reference
Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration
10.1021/js980402t · 1999 · External reference
10.1007/s00894-012-1656-0
10.1007/s00894-012-1656-0 · External reference
Homodimeric tacrine congeners as acetylcholinesterase inhibitors
10.1021/jm010308g · 2002 · External reference
10.1016/j.ceca.2018.05.009
10.1016/j.ceca.2018.05.009 · External reference
10.1016/0006-291x(87)90628-0
10.1016/0006-291x(87)90628-0 · External reference
Prediction of liver toxicity and mode of action using metabolomics in vitro in HepG2 cells
10.1007/s00204-017-2079-6 · 2018 · External reference
10.1111/j.2042-7158.1997.tb06055.x
10.1111/j.2042-7158.1997.tb06055.x · External reference
10.1002/jnr.490350513
10.1002/jnr.490350513 · External reference
Molecular mechanisms of neuroprotection by two natural antioxidant polyphenols
10.1016/j.ceca.2008.12.007 · 2009 · External reference
Immature and mature cortical neurons engage different apoptotic mechanisms involving caspase-3 and the mitogen-activated protein kinase pathway
10.1097/00004647-200208000-00005 · 2002 · External reference
10.5115/acb.2015.48.2.95
10.5115/acb.2015.48.2.95 · External reference
Chemical similarity assisted search for acetylcholinesterase inhibitors: molecular modeling and evaluation of their neuroprotective properties
10.1016/j.ijbiomac.2021.01.148 · 2021 · External reference
Microtubule-associated protein 2 and tubulin are differently distributed in the dendrites of developing neurons
10.1016/0306-4522(86)90253-8 · 1986 · External reference
Protective effects of BDNF and NT-3 but not PDGF against hypoglycemic injury to cultured striatal neurons
10.1016/0014-4886(95)90002-0 · 1995 · External reference
Neural progenitor cells attenuate inflammatory reactivity and neuronal loss in an animal model of inflamed AD brain
10.1186/1742-2094-6-39 · 2009 · External reference
10.1016/s0378-4274(00)00188-0
10.1016/s0378-4274(00)00188-0 · External reference
10.1126/science.164.3880.719
10.1126/science.164.3880.719 · External reference
10.1016/j.ijdevneu.2009.08.016
10.1016/j.ijdevneu.2009.08.016 · External reference
10.1007/s12264-007-0031-0 · 2007 · Admitted local publication
Acute low dose monosodium glutamate retards novelty induced behaviours in male Swiss albino mice
2011 · External reference
10.2165/00002512-199404060-00006
10.2165/00002512-199404060-00006 · External reference
LiCABEDS II. Modeling of ligand selectivity for G-protein-coupled cannabinoid receptors
10.1021/ci3003914 · 2013 · External reference
10.1021/acs.jmedchem.0c01775
10.1021/acs.jmedchem.0c01775 · External reference
10.1073/pnas.0508575102
10.1073/pnas.0508575102 · External reference
Development of an in-vivo active reversible butyrylcholinesterase inhibitor
10.1038/srep39495 · 2016 · External reference
10.1038/nrn1035
10.1038/nrn1035 · External reference
Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease
2018 · External reference
Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors
10.1016/s0028-3908(03)00317-4 · 2004 · External reference
10.1016/j.bmc.2007.10.090
10.1016/j.bmc.2007.10.090 · External reference
10.1038/s41586-018-0039-9
10.1038/s41586-018-0039-9 · External reference
10.1093/nar/gkh368
10.1093/nar/gkh368 · External reference
10.1093/bioinformatics/btl461
10.1093/bioinformatics/btl461 · External reference
iMod: multipurpose normal mode analysis in internal coordinates
10.1093/bioinformatics/btr497 · 2011 · External reference
10.1107/s0907444913021811
10.1107/s0907444913021811 · External reference
WEBnm@ v2.0: Web server and services for comparing protein flexibility
10.1186/s12859-014-0427-6 · 2014 · External reference
REMO: A new protocol to refine full atomic protein models from C-alpha traces by optimizing hydrogen-bonding networks
10.1002/prot.22380 · 2009 · External reference
10.1021/acs.jctc.5b00864
10.1021/acs.jctc.5b00864 · External reference
10.1016/j.cbi.2019.06.011
10.1016/j.cbi.2019.06.011 · External reference
10.1038/srep42717
10.1038/srep42717 · External reference
AlzPlatform: an Alzheimer's disease domain-specific chemogenomics knowledgebase for polypharmacology and target identification research
10.1021/ci500004h · 2014 · External reference
10.1126/science.1678899
10.1126/science.1678899 · External reference
Asymmetric and globular forms of acetylcholinesterase in mammals and birds
10.1073/pnas.76.6.2546 · 1979 · External reference
A new and rapid colorimetric determination of acetylcholinesterase activity
1961 · External reference
10.1016/0165-0270(84)90007-4
10.1016/0165-0270(84)90007-4 · External reference
